Dr. Kim is an Associate Professor of Medicine in the Division of Hematology/Oncology, holds a joint appointment in the Department of Genetics, and is a member of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. Dr. Kim received his M.D. from Brown University and completed his medical residency and oncology fellowship at the Beth Israel Hospital and Dana-Farber Cancer Institute (Harvard Medical School), respectively. A medical oncologist by training, Dr. Kim specializes in the treatment of patients with urothelial carcinoma as well as renal cell carcinoma. His laboratory is focused on understanding the genetic and epigenetic events involved in the initiation and progression of renal cell carcinoma (RCC) and bladder cancer.